Mintel
Stevia market to break $100 million this year
Published in Medical Letter on the CDC and FDA, October 11th, 2009
Since December 2008, when the FDA approved use of rebaudioside A (an active ingredient of stevia) in US food and beverage, the stevia market* has erupted. By mid-July 2009, stevia sales topped $95 million, a substantial increase over the $21 million achieved in all of 2008. Mintel predicts the stevia market could exceed $2 billion by the end of 2011.
"The FDA's approval of stevia in food and drink opened the door for this market's explosion," states David Browne, senior analyst at Mintel. "New product activity...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- JAMA and Archives Journals
Nationwide study examines youth access to indoor tanning - Analgesics
King Announces Commercial Availability of EMBEDA(TM) - BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger - Bioterrorism
FY 2010 Federal Biodefense Spending - Bristol-Myers Squibb
Data Presented from Two Phase 3 ERBITUX(R) Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress - Enzyme Research
Research from University of Cincinnati in the area of enzyme research described - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
